William Farnaby

8PUBLICATIONS
60CO-AUTHORS
Proteins and peptidesProteomics and intermolecular interactions (excl. medical proteomics)Characterisation of biological macromoleculesMolecular targetsWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 06, 2025
Discovery of a CNS active GSK3 degrader using orthogonally reactive linker screening.

Andreas Holmqvist, Nur Mehpare Kocaturk, Christina Duncan

|Sep 29, 2025
Frustration in the protein-protein interface plays a central role in the cooperativity of PROTAC ternary complexes.

Ning Ma, Supriyo Bhattacharya, Sanychen Muk

|Oct 15, 2024
Design of a Cereblon construct for crystallographic and biophysical studies of protein degraders.

Alena Kroupova, Valentina A Spiteri, Zoe J Rutter

|Sep 19, 2024
Targeting cancer with small-molecule pan-KRAS degraders.

Johannes Popow, William Farnaby, Andreas Gollner

|Oct 10, 2022
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo.

Christiane Kofink, Nicole Trainor, Barbara Mair

|Jul 04, 2019
Publisher Correction: BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.

William Farnaby, Manfred Koegl, Michael J Roy

Pageof 2